Charles Cha
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis 25
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 14
- Colorectal Cancer Treatments and Studies 10
- Cancer Treatment and Pharmacology 4
- Cancer Research top 5%
- Otorhinolaryngology top 5%
-
- Prostate Cancer Diagnosis and Treatment 4
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 12
- Organ Transplantation Techniques and Outcomes 5
-
- Microbial metabolism and enzyme function 4
- Co-authors
- Ronald P. DeMatteoLeslie H. BlumgartYuman FongWilliam R. JarnaginRonald W. LewisJohn H. HealeyMarc LadanyiS.C. Jhanwar
- Cited by
- HepatologyOncologyCancer Research
- Journals
- Annals of Surgical Oncology (6 papers)Journal of Surgical Research (5 papers)Journal of Clinical Oncology (5 papers)
- Partner nations
- United StatesChinaHong Kong
In The Last Decade
Charles Cha
78 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 115
- Hepatology 707
- Oncology 973
- Cancer Research 391
- Otorhinolaryngology 101
- Pulmonary and Respiratory Medicine 692
Countries citing papers authored by Charles Cha
This map shows the geographic impact of Charles Cha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Cha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Cha more than expected).
Fields of papers citing papers by Charles Cha
This network shows the impact of papers produced by Charles Cha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Cha. The network helps show where Charles Cha may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Charles Cha, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 3 | |
| 2 | 2023 | 27 | |
| 3 | 2022 | 2 | |
| 4 | 2021 | 6 | |
| 5 | 2020 | 4 | |
| 6 | 2019 | 1 | |
| 7 | 2019 | 54 | |
| 8 | 2018 | 3 | |
| 9 | 2017 | 8 | |
| 10 | 2016 | 45 | |
| 11 | 2016 | 153 | |
| 12 | 2015 | 13 | |
| 13 | 2014 | 41 | |
| 14 | 2014 | 4 | |
| 15 | 2012 | 19 | |
| 16 | 2008 | 43 | |
| 17 | 2006 | 14 | |
| 18 | 2006 | 27 | |
| 19 | 2004 | 133 | |
| 20 | 2003 | 237 |
About Charles Cha
Charles Cha is a scholar working on Hepatology, Oncology and Otorhinolaryngology, having authored 79 papers that have together received 2.5k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (25 papers), Pancreatic and Hepatic Oncology Research (14 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers), Colorectal Cancer Treatments and Studies (10 papers), Organ Transplantation Techniques and Outcomes (5 papers), Microbial metabolism and enzyme function (4 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Cancer Treatment and Pharmacology (4 papers). The work is most often cited by research in Hepatology (707 citations), Oncology (973 citations) and Cancer Research (391 citations). Charles Cha has collaborated with scholars based in United States, China and Hong Kong. Frequent co-authors include Ronald P. DeMatteo, Leslie H. Blumgart, Yuman Fong, William R. Jarnagin, Ronald W. Lewis, John H. Healey, Marc Ladanyi, S.C. Jhanwar, Andrew G. Huvos and Peter S. Yoo. Their work appears in journals such as Annals of Surgical Oncology, Journal of Surgical Research, Journal of Clinical Oncology, Journal of the American College of Surgeons and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.